Overview

Abbott Laboratories Inc. is a pharmaceutical company that develops manufactures and markets a broad line of health care products, headquartered in Abbott Park, Illinois, the US. The company reported revenue of $31.9 billion for the fiscal year ended December 2019 (FY2019The company offers diagnostic systems, neuromodulation devices, medical devices, pediatric and adult nutritional products, and generic pharmaceuticals. Abbott sells its products under various brand names, including Similac, Oxepa, Alinity, Cell-Dyn, Heptral, Duspatal, FlexAbility, HeartMate, and FreeStyle. The company sells its products directly to consumers wholesalers, retailers, healthcare facilities, government agencies, third-party distributors, blood banks, commercial laboratories, clinics, physicians' offices, government agencies, and ambulatory surgery centers. It has R&D facilities in the US, China, Colombia, India, Singapore, Spain, and the UK. The company operates manufacturing facilities across the globe. The company markets its products in North America, Latin America, the Middle East, Europe, Asia-Pacific, and Africa.